Assessing the Long-Term Outcomes of Bariatric Surgery on Metabolic Syndrome and Cardiovascular Health

Dr. Ayesh Anwar; Dr. Muzdah Anwar; Dr. Darya Khan; Dr. Zarmina Farman; Dr. Wajiha Kalsoom; Dr. Abdul Qayum

doi:10.62497/IRABCS.2024.60

Authors

Dr. Ayesh Anwar Peshawar Medical College, Peshawar Author https://orcid.org/0009-0000-8615-8690
Dr. Muzdah Anwar Khyber Girls Medical College, Peshawar Author https://orcid.org/0009-0002-9147-7084
Dr. Darya Khan Nowshera Medical College, Qazi Hussain Ahmad Medical Complex Nowshera Author https://orcid.org/0009-0001-2120-1341
Dr. Zarmina Farman Rehman Medical College Peshawar Author https://orcid.org/0009-0006-9163-8633
Dr. Wajiha Kalsoom Rehman Medical College Peshawar Author https://orcid.org/0009-0006-4244-025X
Dr. Abdul Qayum Saidu Medical College, Swat Author https://orcid.org/0009-0007-0684-2136

DOI:

https://doi.org/10.62497/IRABCS.2024.60

Keywords:

Bariatric Surgery, Metabolic Syndrome X, Cardiovascular Diseases, Body Weight Reduction, Roux-en-Y Anastomosis

Abstract

Background: A key component of treating extreme obesity and the related metabolic syndrome is bariatric surgery. The purpose of this research was to assess the long-term effects of bariatric surgery on patients' cardiovascular and metabolic health at the Rehman Medical Institute General Hospital in Peshawar.

Methods: A retrospective cohort research was carried out on 120 patients who had bariatric surgery performed between 2018 and 2020 (Roux-en-Y gastric bypass, sleeve gastrectomy, or adjustable gastric banding). Over the course of a 5-year follow-up period, data on weight reduction, glycemic control (as determined by fasting blood glucose and HbA1c levels), lipid profiles, blood pressure, cardiovascular events, and death were gathered.

Results: Following surgery, there were notable improvements in every metabolic parameter. The average weight loss was 27.5 kg, and after five years, the average BMI decreased by 9.5 kg/m². With mean fasting blood glucose dropping to 104.7 mg/dL and HbA1c to 6.6%, there was a significant improvement in glucose management. Positive alterations in blood pressure and lipid profiles were also seen. Both mortality and the incidence of cardiovascular events sharply decreased.

Conclusion: This 5-year research shows that bariatric surgery, especially Roux-en-Y gastric bypass, is very beneficial in treating metabolic syndrome and cardiovascular health in addition to causing long-term weight reduction. The results of this study support the notion that bariatric surgery is an essential option for the treatment of extreme obesity and its concomitant conditions. To improve long-term results, further research is required to improve surgical technique and patient selection criteria.

Downloads

Download data is not yet available.

References

Doumouras AG, Wong JA, Paterson JM, Lee Y, Sivapathasundaram B, Tarride JE, Thabane L, Hong D, Yusuf S, Anvari M. Bariatric surgery and cardiovascular outcomes in patients with obesity and cardiovascular disease: a population-based retrospective cohort study. Circulation. 2021 Apr 13;143(15):1468-80. DOI: https://doi.org/10.1161/CIRCULATIONAHA.120.052386.

Aminian A, Zajichek A, Arterburn DE, Wolski KE, Brethauer SA, Schauer PR, Kattan MW, Nissen SE. Association of metabolic surgery with major adverse cardiovascular outcomes in patients with type 2 diabetes and obesity. Jama. 2019 Oct 1;322(13):1271-82. DOI: https://doi.org/10.1001/jama.2019.14231.

Courcoulas AP, King WC, Belle SH, Berk P, Flum DR, Garcia L, Gourash W, Horlick M, Mitchell JE, Pomp A, Pories WJ. Seven-year weight trajectories and health outcomes in the Longitudinal Assessment of Bariatric Surgery (LABS) study. JAMA surgery. 2018 May 1;153(5):427-34. DOI: https://doi.org/10.1001/jamasurg.2017.5025.

Inge TH, Jenkins TM, Xanthakos SA, Dixon JB, Daniels SR, Zeller MH, Helmrath MA. Long-term outcomes of bariatric surgery in adolescents with severe obesity (FABS-5+): a prospective follow-up analysis. The lancet Diabetes & endocrinology. 2017 Mar 1;5(3):165-73. DOI: https://doi.org/10.1016/S2213-8587(16)30315-1

Sheng B, Truong K, Spitler H, Zhang L, Tong X, Chen L. The long-term effects of bariatric surgery on type 2 diabetes remission, microvascular and macrovascular complications, and mortality: a systematic review and meta-analysis. Obesity surgery. 2017 Oct;27:2724-32. DOI: https://doi.org/10.1007/s11695-017-2866-4.

Van Veldhuisen SL, Gorter TM, van Woerden G, de Boer RA, Rienstra M, Hazebroek EJ, Van Veldhuisen DJ. Bariatric surgery and cardiovascular disease: a systematic review and meta-analysis. European Heart Journal. 2022 May 21;43(20):1955-69. DOI: https://doi.org/10.1093/eurheartj/ehac071.

Tune JD, Goodwill AG, Sassoon DJ, Mather KJ. Cardiovascular consequences of metabolic syndrome. Translational Research. 2017 May 1;183:57-70. DOI: https://doi.org/10.1016/j.trsl.2017.01.001.

Syn NL, Cummings DE, Wang LZ, Lin DJ, Zhao JJ, Loh M, Koh ZJ, Chew CA, Loo YE, Tai BC, Kim G. Association of metabolic–bariatric surgery with long-term survival in adults with and without diabetes: a one-stage meta-analysis of matched cohort and prospective controlled studies with 174 772 participants. The Lancet. 2021 May 15;397(10287):1830-41. DOI: https://doi.org/10.1016/S0140-6736(21)00591-2.

Aminian A, Al-Kurd A, Wilson R, Bena J, Fayazzadeh H, Singh T, Albaugh VL, Shariff FU, Rodriguez NA, Jin J, Brethauer SA. Association of bariatric surgery with major adverse liver and cardiovascular outcomes in patients with biopsy-proven nonalcoholic steatohepatitis. Jama. 2021 Nov 23;326(20):2031-42. DOI: https://doi.org/10.1001/jama.2021.19569.

Cardoso L, Rodrigues D, Gomes L, Carrilho F. Short‐and long‐term mortality after bariatric surgery: a systematic review and meta‐analysis. Diabetes, Obesity and Metabolism. 2017 Sep;19(9):1223-32. DOI: https://doi.org/10.1111/dom.12922.

Nguyen NT, Varela JE. Bariatric surgery for obesity and metabolic disorders: state of the art. Nature reviews Gastroenterology & hepatology. 2017 Mar;14(3):160-9. DOI: https://doi.org/10.1038/nrgastro.2016.170.

Fisher DP, Johnson E, Haneuse S, Arterburn D, Coleman KJ, O’Connor PJ, O’Brien R, Bogart A, Theis MK, Anau J, Schroeder EB. Association between bariatric surgery and macrovascular disease outcomes in patients with type 2 diabetes and severe obesity. Jama. 2018 Oct 16;320(15):1570-82. DOI: https://doi.org/10.1001/jama.2018.14619.

Adams TD, Davidson LE, Litwin SE, Kim J, Kolotkin RL, Nanjee MN, Gutierrez JM, Frogley SJ, Ibele AR, Brinton EA, Hopkins PN. Weight and metabolic outcomes 12 years after gastric bypass. New England Journal of Medicine. 2017 Sep 21;377(12):1143-55. DOI: https://doi.org/10.1056/NEJMoa1700459.

Arterburn DE, Telem DA, Kushner RF, Courcoulas AP. Benefits and risks of bariatric surgery in adults: a review. Jama. 2020 Sep 1;324(9):879-87. DOI: https://doi.org/10.1001/jama.2020.12567.

Thereaux J, Lesuffleur T, Païta M, Czernichow S, Basdevant A, Msika S, Millat B, Fagot-Campagna A. Long-term follow-up after bariatric surgery in a national cohort. Journal of British Surgery. 2017 Sep;104(10):1362-71. DOI: https://doi.org/10.1002/bjs.10557.

Jakobsen GS, Småstuen MC, Sandbu R, Nordstrand N, Hofsø D, Lindberg M, Hertel JK, Hjelmesæth J. Association of bariatric surgery vs medical obesity treatment with long-term medical complications and obesity-related comorbidities. Jama. 2018 Jan 16;319(3):291-301. DOI: https://doi.org/10.1001/jama.2017.21055.

Carlsson LM, Sjöholm K, Karlsson C, Jacobson P, Andersson-Assarsson JC, Svensson PA, Larsson I, Hjorth S, Neovius M, Taube M, Carlsson B. Long-term incidence of microvascular disease after bariatric surgery or usual care in patients with obesity, stratified by baseline glycaemic status: a post-hoc analysis of participants from the Swedish Obese Subjects study. The lancet Diabetes & endocrinology. 2017 Apr 1;5(4):271-9. DOI: https://doi.org/10.1016/S2213-8587(17)30061-X.

Doumouras AG, Lee Y, Paterson JM, Gerstein HC, Shah BR, Sivapathasundaram B, Tarride JE, Anvari M, Hong D. Association between bariatric surgery and major adverse diabetes outcomes in patients with diabetes and obesity. JAMA network open. 2021 Apr 1;4(4):e216820-. DOI: https://doi.org/10.1001/jamanetworkopen.2021.6820

Lupoli R, Lembo E, Saldalamacchia G, Avola CK, Angrisani L, Capaldo B. Bariatric surgery and long-term nutritional issues. World journal of diabetes. 2017 Nov 11;8(11):464. DOI: https://doi.org/10.4239/wjd.v8.i11.464.

Wiggins T, Guidozzi N, Welbourn R, Ahmed AR, Markar SR. Association of bariatric surgery with all-cause mortality and incidence of obesity-related disease at a population level: a systematic review and meta-analysis. PLoS medicine. 2020 Jul 28;17(7):e1003206. DOI: https://doi.org/10.1371/journal.pmed.1003206.

Aminian A, Wilson R, Al-Kurd A, Tu C, Milinovich A, Kroh M, Rosenthal RJ, Brethauer SA, Schauer PR, Kattan MW, Brown JC. Association of bariatric surgery with cancer risk and mortality in adults with obesity. Jama. 2022 Jun 28;327(24):2423-33. DOI: https://doi.org/10.1001/jama.2022.9009.

Eisenberg D, Shikora SA, Aarts E, Aminian A, Angrisani L, Cohen RV, De Luca M, Faria SL, Goodpaster KP, Haddad A, Himpens JM. 2022 American Society of Metabolic and Bariatric Surgery (ASMBS) and International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) indications for metabolic and bariatric surgery. DOI: https://doi.org/10.1016/j.soard.2022.08.013.